Unspecified Strokes: Time Trends, Determinants, and Long-Term Prognosis in the General Population by Heshmatollah, A. (Alis) et al.
Original Paper
Neuroepidemiology
Unspecified Strokes: Time Trends, 
Determinants, and Long-Term  
Prognosis in the General Population
Alis Heshmatollah a, b    Unal Mutlu a    L. Paloma Rojas-Saunero a    
Marileen L.P. Portegies a    Renske G. Wieberdink a    Peter J. Koudstaal b    
M. Kamran Ikram a, b    M. Arfan Ikram a    
a
 Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands;  
b
 Department of Neurology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
Received: November 28, 2019
Accepted: January 14, 2020
Published online: February 14, 2020
M. Arfan Ikram, MD, PhD
Department of Epidemiology
Erasmus MC University Medical Center
PO Box 2040, Rotterdam (The Netherlands)
E-Mail m.a.ikram @ erasmusmc.nl
© 2020 The Author(s)
Published by S. Karger AG, Basel
E-Mail karger@karger.com
www.karger.com/ned
DOI: 10.1159/000506130
Keywords
Cerebral infarction · Cerebral hemorrhage · Diagnosis · 
Mortality · Cohort studies
Abstract
Introduction: In the absence of neuroimaging, a stroke is 
typically labelled as unspecified. While the majority of clinic-
based stroke research focuses on hemorrhagic or ischemic 
stroke, in the general population, a substantial proportion of 
strokes remains unspecified. Objective: To investigate time 
trends in the occurrence and determinants of unspecified 
strokes and differences in patient characteristics and surviv-
al compared to ischemic or hemorrhagic stroke. Methods: 
We included 1,546 participants from the population-based 
Rotterdam Study who suffered a first-ever stroke during fol-
low-up (1990–2016). We calculated the proportion of un-
specified strokes per year and compared their characteristics 
between 3 time periods (1990–1999, 2000–2009, and 2010–
2016) using a chi-square test, and furthermore investigated 
differences between unspecified, ischemic, and hemorrhag-
ic stroke in patient characteristics and survival using age- 
and sex-adjusted survival curves. Results: The occurrence of 
unspecified stroke among all strokes decreased from 75% in 
1990 to 16% in 2016. Compared to the first time period 
(1991–1999), diagnosis of unspecified strokes was more of-
ten done by nursing home physicians (13 vs. 40%) and un-
specified stroke patients had more often dementia (30 vs. 
43%) in the last time period (2010–2016). Compared to pa-
tients with ischemic or hemorrhagic stroke, patients with un-
specified stroke were on average older (84.3 vs. 78.5 years) 
and had more often physical impairments and dementia. 
Furthermore, patients with unspecified stroke had a lower 
survival probability up to 10 years after stroke than those 
with ischemic stroke. Conclusions: The proportion of un-
specified strokes decreased drastically from 75 to 16% in the 
last decades. Patients who do not undergo neuroimaging 
and therefore are classified as unspecified stroke represent 
an older, more frail patient group that suffers more often 
from multimorbidities and poor long-term prognosis than 
those who do undergo neuroimaging and are thus classified 
as ischemic or hemorrhagic stroke.
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Introduction
In patients with a clinical diagnosis of stroke, neuro-
imaging in an outpatient clinic or hospital is essential to 
distinguish between the subtypes of stroke, that is, isch-
emic or hemorrhagic stroke. In absence of neuroimaging, 
the stroke remains per definition unspecified. Reasons for 
the absence of neuroimaging include nonreferral by pri-
mary care physicians, death before reaching an imaging 
unit, or refusal of further medical care by a patient. For 
these reasons, the incidence of unspecified stroke is dif-
ficult to ascertain from clinic-based studies. In contrast, 
population-based studies that capture stroke incidence 
from primary and secondary care have reported that 
2–52% of all strokes remain unspecified [1–9]. However, 
these patients are often excluded from analysis, poten-
tially introducing selection bias since the reason that a 
stroke remains unspecified is most likely not at random.
In the past decades, the treatment of stroke has im-
proved considerably with the implementation of dedicat-
ed stroke units, intravenous thrombolysis and, more re-
cently, endovascular thrombectomy [10–12]. In addition, 
specialized outpatient clinics have been set up to rapidly 
evaluate and initiate secondary preventive treatment of 
patients with a mild stroke or transient ischemic attack 
[13, 14]. Given abovementioned improvements in stroke 
care and the increased awareness of stroke symptoms 
among patients and physicians, it is plausible that the 
threshold for referral and undergoing diagnostic proce-
dures has lowered in recent decades. This should then 
translate into a lower proportion of strokes remaining 
unspecified. Nevertheless, a certain proportion of all 
strokes remain unspecified, and it is unclear in what as-
pects these patients differ from those who undergo neu-
roimaging. Such insights may facilitate generalization of 
findings from specified stroke subtypes to the entire 
stroke population and may also provide leads for im-
proved stroke management in the primary care.
Therefore, we investigated time trends in the occur-
rence of unspecified strokes in the past decades. We fur-
thermore studied whether there were differences in patient 
characteristics and survival between patients with unspec-
ified stroke and those with ischemic or hemorrhagic stroke.
Methods
Study Setting and Population
This study is based on the Rotterdam Study, a large prospective 
population-based cohort study in the Netherlands that investigates 
causes and consequences of chronic diseases in the general popula-
tion [15]. The cohort was initiated in 1990 and was expanded in 
2000 and 2006, with a total of 14,926 participants aged 45 years or 
older. For the current study, participants with a prior stroke at 
study entry (n = 459) and participants who did not give permission 
to review their medical records for incident stroke (n = 295) were 
excluded. The remaining 14,172 participants were followed up un-
til January 2016 for the occurrence of stroke.
Assessment of Stroke
Stroke was defined according to the World Health Organiza-
tion criteria as a syndrome of rapidly developing clinical signs of 
focal or global disturbance of cerebral function, with symptoms 
lasting 24 h or longer or leading to death, with no apparent cause 
other than of vascular origin [16]. History of stroke was assessed 
during baseline interview and verified by reviewing medical re-
cords obtained from general practitioners. After enrollment, par-
ticipants were continuously monitored for incident stroke through 
automated linkage of the study database with files from general 
practitioners and nursing home physicians. Files from nursing 
home physicians and from general practitioners of participants 
who moved out of the district were also checked on a regular basis. 
Additional information was obtained from hospital records. The 
information collected on potential strokes was reviewed and struc-
tured by research physicians and verified by experienced stroke 
neurologists in a consensus panel. Strokes were further classified 
as ischemic or hemorrhagic based on neuroimaging reports. If 
neuroimaging was lacking, a stroke was classified as unspecified. 
This classification corresponds with ICD-10 codes I61, I63, and 
I64. Follow-up from first stroke until death or January 2016 was 
virtually complete (97.4%).
Assessment of Patient Characteristics
Participants were interviewed at home every 4 years with stan-
dardized questionnaires on health status, medication use, and 
medical history. They additionally visited the research center for 
extensive physical examination. Body mass index was calculated as 
weight (kg) divided by the square of height (m2). Blood pressure 
was measured at the right upper arm using a sphygmomanometer 
during 2 consecutive readings, and the average of the 2 readings 
was used for further analysis. Blood samples were drawn to assess 
lipid and glucose levels. Diabetes mellitus type 2 was defined as a 
fasting glucose of ≥7.0 mmol/L, a nonfasting or postload serum 
glucose of ≥11.1 mmol/L, or use of blood glucose-lowering medi-
cation. Smoking behavior was classified as current, former, or nev-
er. Education was divided into primary; lower/intermediate edu-
cation; intermediate vocational or higher general education; and 
higher vocational education or university. The assessment of de-
mentia is extensively described elsewhere [17]. We used data on 
the patients’ characteristics of the most recent center visit prior to 
the incident stroke.
Statistical Analysis
First, we calculated the proportion of ischemic, hemorrhagic, 
and unspecified stroke for every year of follow-up between 1990 
and 2016. We then divided the years of follow-up into 3 time periods 
(1990–1999, 2000–2009, and 2010–2016) and assessed the propor-
tion of stroke subtypes in these periods stratified by 5-year age cat-
egories. Furthermore, we compared characteristics of participants 
with unspecified stroke across these 3 time periods using contin-
gency tables and a chi-square test and stratified by sex. To compare 
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stroke subtypes, we calculated the frequencies and averages of dif-
ferent patient characteristics for ischemic, hemorrhagic, and un-
specified stroke. Finally, we estimated survival after first stroke and 
the risk difference between stroke subtypes using age- and sex-ad-
justed survival curves. This method uses standardization to repre-
sent the survival if everyone had suffered an unspecified stroke 
compared to if everyone had suffered an ischemic or hemorrhagic 
stroke [18]. We assumed that follow-up until death was complete 
and used bootstrapping with 1,000 runs to construct CIs. For com-
parison, we added the Kaplan-Meier estimator. All analyses were 
performed using IBM SPSS version 24.0 and R 3.6.1 software.
Results
During a mean (SD) follow-up of 11.8 years (9.8) be-
tween 1990 and 2016, 1,546 participants suffered a stroke. 
Overall, 944 (61%) were classified as ischemic, 137 (9%) 
as hemorrhagic, and 465 (30%) as unspecified stroke.
Time Trends of Unspecified Stroke
Between 1990 and 2016, the proportion of unspecified 
strokes decreased steadily from 75% in 1990 to 28% in 
2000 and 16% in 2016 (Fig. 1). In contrast, the proportion 
of ischemic strokes increased from 25% in 1990 to 68% in 
2016, and the percentage of hemorrhagic strokes fluctu-
ated between 1 and 16%.
Stratification per 5-year age category shows that the 
proportion of unspecified strokes was higher in the el-
derly throughout all time periods (Fig. 2). However, also 
within the elderly, we observed a proportional decrease of 
unspecified strokes over time. In the most recent time pe-
riod, patients whose stroke remained unspecified were 
significantly more often diagnosed by nursing home phy-
sicians or the general practitioner and less often by a neu-
rologist compared to earlier time periods (Table 1). Sim-
ilarly, we found that fewer patients with unspecified 
stroke were hospitalized between 2000 and 2016 com-
pared to the previous time periods. Furthermore, patients 
with unspecified stroke were more often diagnosed with 
dementia prior to the event.
Differences between Stroke Subtypes
Patients with an unspecified stroke were on average 
older, were more often women, and suffered more fre-
quently from multimorbidity such as dementia, diabetes 
mellitus type 2, and prior transient neurological attacks 
at the time of stroke than those with either ischemic or 
hemorrhagic stroke (Table 2). The diagnosis in patients 
with unspecified stroke was primarily made by the gen-
eral practitioner (52%) or nursing home physician (24%), 
whereas in patients with ischemic or hemorrhagic stroke 
this was mainly the neurologist (85 and 91%, respective-
ly). Stratification by sex showed that women with unspec-
ified stroke were older, were more often diagnosed by a 
nursing home physician, and suffered more often from 
dementia than men with unspecified stroke (online suppl. 
Table S1, see www.karger.com/doi/10.1159/000506130).
With regard to survival, the age- and sex-adjusted sur-
vival curves show that patients with an unspecified stroke 
had a lower probability of survival than those with isch-
emic stroke. One year after the stroke, patients with un-
specified stroke had an 18% (95% CI 13–23%) lower prob-
ability of survival than those with ischemic stroke (Fig. 3a). 
This poor prognosis in patients with unspecified stroke 
compared to those with ischemic stroke extended to up to 
10 years after stroke. However, comparing the survival to 
patients with hemorrhagic stroke, those with unspecified 
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Fig. 1. Time trends of the proportion of 
stroke subtypes over calendar years. We 
calculated the proportion of ischemic 
(blue), hemorrhagic (red) and unspecified 
(green) stroke for every year of follow-up 
between 1990 and 2016. Over time, the 
proportion of unspecified stroke is de-
creasing over time, whereas the proportion 
of ischemic stroke is increasing and the 
proportion of hemorrhagic stroke remains 
stable.
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stroke had a 30% (95% CI 19–38%) higher survival prob-
ability after 1 year (Fig. 3b). The Kaplan-Meier estimator 
likewise found a lower survival probability for both un-
specified and hemorrhagic stroke compared to ischemic 
stroke, but no substantial differences between unspecified 
and hemorrhagic stroke were found (Fig. 3c).
Discussion
In this prospective population-based study, we found 
that the occurrence of unspecified strokes decreased from 
75% in 1990 to a mere 16% in 2016. This decline was seen 
throughout all ages including the very elderly. Over time, 
the diagnosis of unspecified stroke was relatively more 
often made by nursing home physicians, and patients had 
more frequently dementia at stroke diagnosis. When 
comparing stroke subtypes, patients with an unspecified 
stroke were older, more often women and suffered more 
frequently from multimorbidity at stroke diagnosis than 
those with ischemic or hemorrhagic stroke. Also, patients 
with unspecified stroke had a higher probability of death 
immediately and up to 10 years after the event than those 
with ischemic stroke.
Other population-based studies have reported a pro-
portion of unspecified strokes between 2 and 52% [1–9] 
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and show that patients under 65 years were rarely diag-
nosed with an unspecified stroke [1, 2, 6, 7, 19, 20]. These 
are lower proportions than in our study. One of the main 
reasons is that the majority of these studies did not exam-
ine nursing home records but ascertained cases from hos-
pital records, death certificates and, less often, general 
practitioners or family physicians in the area [1, 4, 5, 7–9]. 
Our study shows that most patients of whom the stroke 
remained unspecified lived in nursing homes. Further-
more, in the nineties when imaging was not readily avail-
able, it was accepted clinical practice to subtype stroke 
purely based on clinical symptomatology [21, 22]. After 
the turn of the millennium, with scanners becoming less 
expensive and more accessible to routine practice, the 
current consensus emerged that a stroke without imaging 
remains per definition unspecified irrespective of symp-
tomatology. This evolving practice likely explains why in 
the early years of follow-up in our study, the proportion 
of unspecified stroke defined according to current guide-
lines is relatively high, that is, 75% in 1990. Yet, it is note-
worthy that already in those early years the proportion of 
unspecified stroke started decreasing, that is, in 1991 to 
67% and in 1992 to 41%.
Studies that examined time trends showed a similar 
decrease over time in proportion of unspecified stroke, 
for example, from 52 to 9% [9, 19]. Several reasons could 
underlie this decrease in occurrence. First, it indicates 
that more patients with a clinical diagnosis of stroke are 
referred to a hospital. Current standard treatment for 
ischemic stroke, intravenous and endovascular, requires 
immediate referral and further stroke subtype specifica-
tion by CT or MRI-scan. Age is also becoming less of a 
barrier for referral as thrombolytic and endovascular 
treatments do not have an upper age limit. Likewise, el-
derly patients benefit from being hospitalized to a stroke 
unit [23] and, despite the higher complication rate com-
pared to younger patients, have a better prognosis than 
elderly patients without treatment [10, 24]. Patients, who 
are still not referred, seem to represent a group of more 
frail patients declining further medical care or having sev-
eral multimorbidities such as dementia and physical dis-
abilities. In this patient group, advance directives are in-
creasingly implemented and play an important role to en-
sure that the provided care and treatment are consistent 
with patients’ wishes [25]. Our study confirms that pa-
tients with unspecified stroke were often diagnosed by a 
nursing home physician and had more often dementia. 
Second, neuroimaging is routinely performed nowadays 
in hospitals and therefore less strokes remain unspecified 
[26]. Third, due to increased awareness of stroke symp-
toms due to public campaigns, stroke symptoms are ear-
lier recognized and thus less patients die before reaching 
an imaging unit [7, 27].
When comparing stroke subtypes, we found that pa-
tients with an unspecified stroke were older, more often 
women and displayed more multimorbidity than those 
with ischemic or hemorrhagic stroke. Within popula-
tion-based studies, limited research has been done on the 
Table 1. Characteristics of patients with unspecified stroke by different time periods
1990–1999 (n = 229) 2000–2009 (n = 200) 2010–2016 (n = 35)
Age, years, mean (SD) 84.3 (8.2) 86.7 (6.6) 85.2 (10.4)
Gender, women, n (%) 159 (69.4) 142 (71.0) 24 (68.6)
Diagnosing physician, n (%)*
General practitioner
Nursing home physician
Neurologist
Other physician
Missing
128 (55.9)
29 (12.7)
39 (17.0)
14 (6.1)
19 (8.3)
90 (45.0)
58 (29.0)
36 (18.0)
11 (5.5)
5 (2.5)
15 (42.9)
14 (40.0)
2 (5.7)
3 (8.6)
1 (2.9)
Hospitalization after stroke, n (%)
Yes
No
Missing or unknown
48 (21.0)
166 (72.5)
15 (6.6)
40 (20.0)
145 (72.5)
15 (7.5)
3 (8.6)
29 (82.9)
3 (8.6)
Demented at stroke diagnosis, n (%)
Yes
No
Missing
69 (30.1)
147 (64.2)
13 (5.7)
69 (34.5)
121 (60.5)
10 (5.0)
15 (42.9)
18 (51.4)
2 (5.7)* Significant difference between periods.
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difference in patient characteristics or prognosis between 
unspecified stroke and ischemic or hemorrhagic stroke. 
One study found that patients with unspecified strokes 
are older than those with other stroke subtypes [2], and 
none found sex differences that could not be explained by 
age [4, 5]. Our study also suggests that women were more 
often diagnosed with unspecified stroke than men, prob-
ably due to a higher age and dementia at stroke diagnosis. 
We did not find differences in hospitalization between 
men and women. Previous research has also not found 
any racial differences between stroke subtypes [8]. Re-
search within hospital- and registry-based studies should 
be interpreted with caution as they represent only a sub-
group of patients with unspecified stroke that were re-
ferred to a hospital. Also, register-based studies represent 
a heterogeneous group of patients due to possible errors 
in the registration of stroke subtypes and performed ex-
aminations such as neuroimaging [28–30]. This becomes 
evident as these studies show a very low (1–6%) [31–37] 
or very high proportion (26–53%) [28, 29, 38–40] of un-
specified stroke. Within these studies, patients with un-
specified stroke were older [32, 33] and had more disabil-
ity before stroke than those with ischemic or hemorrhag-
ic stroke [32]. Patients with unspecified stroke did not 
have more vascular risk factors except for a higher preva-
lence of diabetes mellitus and heart failure [33, 40]. Fi-
Table 2. Patient characteristics by stroke subtype
Characteristic* Ischemic
(n = 944)
Hemorrhagic
(n = 137)
Unspecified
(n = 465)
Age at stroke, years, mean (SD) 77.8 (8.5) 77.8 (8.3) 85.4 (7.8)
Gender, women, n (%) 523 (55.4) 76 (55.5) 325 (69.9)
Highest educational level, n (%)
Primary
Lower/intermediate
Intermediate vocational/higher general
Higher vocational or university
178 (20.0)
365 (40.9)
266 (29.8)
83 (9.3)
21 (16.7)
54 (42.9)
39 (31.0)
12 (9.5)
153 (37.5)
150 (36.8)
81 (19.9)
24 (5.9)
Systolic blood pressure, mm Hg, mean (SD) 152 (23) 155 (26) 152 (25)
Diastolic blood pressure, mm Hg, mean (SD) 78 (12) 81 (14) 76 (13)
Total cholesterol, mmol/L, mean (SD) 5.9 (1.2) 5.8 (1.2) 6.1 (1.2)
BMI, kg/m2, mean (SD) 27.3 (3.9) 26.3 (3.9) 26.5 (3.9)
Smoking, n (%)
Never
Former
Current
290 (32.7)
372 (42.0)
224 (25.3)
37 (28.7)
63 (48.8)
29 (22.5)
183 (44.7)
159 (38.9)
67 (16.4)
Physical limitations before stroke, n (%)
None to mild
Moderate to severe
484 (84.8)
87 (15.2)
74 (81.3)
17 (18.7)
112 (56.9)
85 (43.1)
Diabetes mellitus type 2, n (%) 173 (27.3) 26 (28.0) 85 (38.1)
Prior transient neurological attack, n (%) 181 (20.0) 17 (13.1) 99 (23.2)
Prevalent dementia, n (%) 67 (7.3) 15 (11.1) 153 (34.8)
Diagnosis made by, n (%)
General practitioner
Nursing home physician
Neurologist
Other physician
Missing
15 (1.6)
5 (0.5)
888 (94.1)
27 (2.9)
9 (0.9)
0
0
125 (91.2)
9 (6.6)
3 (2.2)
233 (50.1)
101 (21.7)
78 (16.8)
28 (6.0)
25 (5.4)
Hospitalized after stroke, n (%)
Yes
No
Unknown or missing
681 (72.1)
243 (25.7)
20 (2.1)
132 (96.4)
5 (3.6)
0
91 (19.6)
341 (73.3)
33 (7.1)* Data on blood pressure, smoking, BMI, cholesterol, HDL was missing in patients that did not visit the re-
search center or had a stroke before their first visit (hemorrhagic n = 7, ischemic n = 40, unspecified n = 38). 
Other missing data varied between 0 and 13%, except for diabetes mellitus type 2 (36% missing).
BMI, body mass index.
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nally, hospitalized patients with unspecified stroke were 
less likely to receive secondary preventive medication 
[32] and were more likely to die if they were admitted to 
units other than a stroke unit compared to those with oth-
er stroke subtypes [36].
Most population-based studies showed the highest 
case fatality in patients with unspecified stroke ranging 
from 33 to 69% [1, 2, 6, 20]. Studies with a longer follow-
up found that nearly all patients (88–93%) with unspeci-
fied stroke died within 6–12 months [2, 5, 6]. Hospital-
based studies showed a similar in-hospital mortality of 
unspecified stroke, ranging from 43 to 65%, and those 
who survived were seldom ADL independent [9, 32, 33, 
37]. One study reported a lower mortality of 19%, though 
the authors did not provide a definition of unspecified 
stroke [39]. None of the abovementioned studies, how-
ever, corrected for age and sex. The Kaplan-Meier estima-
tor, for example, is unadjusted for covariates and there-
fore can be confounded. By using adjusted survival curves, 
we estimated that patients with unspecified stroke had a 
higher probability of death than those with ischemic 
stroke but had a better outcome than those with hemor-
rhagic stroke. However, an important note is that we had 
no information on withdrawal of care and its impact on 
survival in these patients. It is conceivable that patients 
with unspecified stroke, being older and having more co-
morbidities, withdrew more often from care thus result-
ing in poor survival after the stroke event. Hence, it is not 
known what the survival difference between stroke sub-
types would have been had all patients received full care.
Limitations of this study need to be addressed. We did 
not systematically assess the severity of strokes and there-
fore could not determine whether patients with an un-
specified stroke had a more severe stroke and therefore 
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Fig. 3. Survival curves stratified by stroke subtype. Age- and sex-
adjusted survival curves (a, b) and Kaplan-Meier curve (c) show-
ing the survival probability after first stroke, stratified by stroke 
subtype. a, b The shaded areas represent 95% CIs and show that 
unspecified stroke patients have a higher probability of death than 
those with ischemic stroke up to 10 years after the event but a low-
er probability of death compared to those with hemorrhagic stroke. 
The Kaplan-Meier curve shows a higher probability of death in 
patients with unspecified stroke compared to ischemic stroke but 
not compared to hemorrhagic stroke.
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had a worse outcome. Furthermore, we were not able to 
differentiate between patients who were diagnosed with 
an unspecified stroke due to non-referral, death before 
reaching an imaging unit or decline of further medical 
care. The strengths of this study are its population-based 
setting which provides insight on all patients with clinical 
stroke symptoms who were seen by a physician, including 
those who were not referred. Furthermore, the age- and 
sex-adjusted survival curves, combined with the long fol-
low-up, provided accurate estimates of the outcome of 
different stroke subtypes.
Conclusion
In conclusion, the occurrence of unspecified strokes has 
decreased drastically over the past 3 decades, indicating 
that more patients with clinical symptoms of stroke are re-
ferred to a hospital. Nevertheless, the patients who remain 
with an unspecified stroke represent a frail patient group 
who are older, more often suffer from dementia and mul-
timorbidities, and are usually not hospitalized. Patients 
with unspecified stroke also have a higher probability of 
death than those with ischemic stroke up to 10 years after 
the stroke. In population-based studies, these patients 
should not be excluded as it introduces selection bias.
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